Marijuana legalization movements in Canada and the United States have created a profit opportunity here that goes beyond ordinary marijuana stocks...
June saw some incredibly exciting developments in the marijuana industry. On June 5, Canada's Senate passed a law that legalized recreational marijuana in Canada.
Meanwhile, the U.S. Food and Drug Administration granted approval for Epidiolex - the nation's first cannabis-based drug that will be used to treat rare forms of epilepsy.
You see, Epidiolex, manufactured by GW Pharmaceuticals Plc. ADR (Nasdaq: GWPH), is based on cannabidiol (CBD), a major component in marijuana plants. Unlike the better-known tetrahydrocannabinol (THC), this compound doesn't get users high.
In fact, CBD is known to help treat opioid addiction, brain cancer, Lou Gehrig's disease, and autism - making it popular in the medical research community.
Pot Stock Profits: A historic event is unfolding in California's marijuana markets, and the wealth expected to flow into this industry is record-breaking. Learn how to cash in here...
This is why Money Morning Defense and Tech Specialist Michael A. Robinson expects Epidiolex generate at least $1.7 billion for GW Pharmaceuticals by 2026.
However, these kinds of profits are just the beginning...
According to Michael, CBD-based products are likely to constitute a $55.8 billion market by 2025.
And Michael has identified a Canadian company at the center of the CBD boom. Michael first recommended this cannabis firm two year ago. Since then, its performance has proved Michael right time and time again.
In May, the company uplisted, making shares of the company available on the New York Stock Exchange as well as the Toronto Stock Exchange. The move has gained this little-known company a wider audience and access to tremendous amounts of capital to fuel growth.
In fact, this marijuana stock just raised $500 million - the largest amount ever for a cannabis company...
This Is the Best Way to Play the Cannabis Boom
[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]
Canopy Growth Corp. (NYSE: CGC) is Canada's largest and fastest-growing cannabis company.
Over the last year, Canopy has heavily invested in cannabis oil products. Because of its higher profit margins, cannabis oil has driven a 30% rise in company revenue and a 107% jump in cannabis oil sales overall.
This rapid rise in sales has driven Canopy to push its sales internationally, striking export agreements with Germany, Australia, Spain, Denmark, Jamaica, Chile, and Brazil.
Corporate investors have taken a keen interest in Canopy as it aggressively expands. Constellation Brands Inc. (NYSE: STZ) established a 9.9% stake in the company and is rumored to be considering an even larger investment.
Canopy has also raised a tremendous amount of capital from its public offerings. In June, the company raised $500 million CAN through a convertible note offering - the largest ever in the cannabis market.
Access to this level of capital gives Canopy the resources to dominate the cannabis industry as it continues to expand.
In fact, Canopy is expected to expand beyond the cannabis industry as local and federal governments accept the medicinal properties of marijuana.
In fact, the 2018 midterm election could open the floodgates to marijuana investment...
This $1.3 Million Profit Opportunity Is Unfolding at the Ballot Box
U.S. President Donald Trump's recent earth-shattering announcement to support ending the federal ban on marijuana sent shock waves throughout the legal cannabis industry.
And with a record 16 states voting on legalizing marijuana this November, it's clear that the industry is headed for historic heights.
Time and again, we've witnessed this pattern - marijuana legalization passes, pot stocks take off, and early investors have the chance to mint millions.
But this news has the potential to spark even bigger profits than what we've seen already... and could help you turn a small stake into a $1.3 million fortune.